304 related articles for article (PubMed ID: 21694613)
1. A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder.
Khan A; Joyce M; Atkinson S; Eggens I; Baldytcheva I; Eriksson H
J Clin Psychopharmacol; 2011 Aug; 31(4):418-28. PubMed ID: 21694613
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
Merideth C; Cutler AJ; She F; Eriksson H
Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.
Stein DJ; Bandelow B; Merideth C; Olausson B; Szamosi J; Eriksson H
Hum Psychopharmacol; 2011 Dec; 26(8):614-28. PubMed ID: 22143997
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.
Mezhebovsky I; Mägi K; She F; Datto C; Eriksson H
Int J Geriatr Psychiatry; 2013 Jun; 28(6):615-25. PubMed ID: 23070803
[TBL] [Abstract][Full Text] [Related]
5. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial.
Katzman MA; Brawman-Mintzer O; Reyes EB; Olausson B; Liu S; Eriksson H
Int Clin Psychopharmacol; 2011 Jan; 26(1):11-24. PubMed ID: 20881846
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
7. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder.
Montgomery SA; Locklear JC; Svedsäter H; Eriksson H
Int Clin Psychopharmacol; 2014 Sep; 29(5):252-62. PubMed ID: 24394383
[TBL] [Abstract][Full Text] [Related]
9. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H
Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
12. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
13. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
Lindenmayer JP; Brown D; Liu S; Brecher M; Meulien D
Psychopharmacol Bull; 2008; 41(3):11-35. PubMed ID: 18779774
[TBL] [Abstract][Full Text] [Related]
17. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
[TBL] [Abstract][Full Text] [Related]
18. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
[TBL] [Abstract][Full Text] [Related]
19. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2014 Feb; 26(1):3-18. PubMed ID: 24660224
[TBL] [Abstract][Full Text] [Related]
20. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
Sheehan DV; Locklear J; Svedsäter H; Datto C
Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]